Moderna inks deal for overseas Covid-19 vaccine finishing work as European approval hangs in balance
Despite a lack of formal approval from the European Medicines Agency, Moderna is moving to nail down production capacity for the doses of its mRNA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.